PowerUp Acquisition (PWUP) Competitors $0.38 -0.04 (-8.62%) As of 10/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock PWUP vs. MTNB, ADXN, AEON, ALBT, EPIX, QLGN, KPRX, ERNA, RNAZ, and NLSPShould you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Matinas Biopharma (MTNB), Addex Therapeutics (ADXN), AEON Biopharma (AEON), Avalon GloboCare (ALBT), ESSA Pharma (EPIX), Qualigen Therapeutics (QLGN), Kiora Pharmaceuticals (KPRX), Ernexa Therapeutics (ERNA), TransCode Therapeutics (RNAZ), and NLS Pharmaceutics (NLSP). These companies are all part of the "pharmaceutical products" industry. PowerUp Acquisition vs. Its Competitors Matinas Biopharma Addex Therapeutics AEON Biopharma Avalon GloboCare ESSA Pharma Qualigen Therapeutics Kiora Pharmaceuticals Ernexa Therapeutics TransCode Therapeutics NLS Pharmaceutics PowerUp Acquisition (NASDAQ:PWUP) and Matinas Biopharma (NYSE:MTNB) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk. Which has more volatility & risk, PWUP or MTNB? PowerUp Acquisition has a beta of 0.05, meaning that its share price is 95% less volatile than the S&P 500. Comparatively, Matinas Biopharma has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Which has preferable valuation & earnings, PWUP or MTNB? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPowerUp AcquisitionN/AN/AN/AN/AN/AMatinas BiopharmaN/AN/A-$22.94M-$3.89-0.50 Does the media favor PWUP or MTNB? In the previous week, Matinas Biopharma had 2 more articles in the media than PowerUp Acquisition. MarketBeat recorded 2 mentions for Matinas Biopharma and 0 mentions for PowerUp Acquisition. Matinas Biopharma's average media sentiment score of 0.50 beat PowerUp Acquisition's score of 0.00 indicating that Matinas Biopharma is being referred to more favorably in the news media. Company Overall Sentiment PowerUp Acquisition Neutral Matinas Biopharma Positive Is PWUP or MTNB more profitable? PowerUp Acquisition's return on equity of 0.00% beat Matinas Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets PowerUp AcquisitionN/A N/A N/A Matinas Biopharma N/A -123.06%-94.28% Do institutionals & insiders hold more shares of PWUP or MTNB? 19.2% of PowerUp Acquisition shares are held by institutional investors. Comparatively, 11.8% of Matinas Biopharma shares are held by institutional investors. 48.0% of PowerUp Acquisition shares are held by insiders. Comparatively, 4.6% of Matinas Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate PWUP or MTNB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PowerUp Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Matinas Biopharma 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryPowerUp Acquisition and Matinas Biopharma tied by winning 4 of the 8 factors compared between the two stocks. Get PowerUp Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PWUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PWUP vs. The Competition Export to ExcelMetricPowerUp AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$2.98M$251.72M$2.51B$10.58BDividend YieldN/A6.55%2.53%4.69%P/E RatioN/A0.1726.7126.70Price / SalesN/A442.98116.59131.81Price / CashN/A123.7047.7861.31Price / BookN/A7.1436.546.55Net IncomeN/A-$12.18M$9.75M$277.50M7 Day Performance6.82%1.44%1.91%2.41%1 Month Performance-34.48%15.54%4.15%9.30%1 Year PerformanceN/A263.48%60.37%31.22% PowerUp Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PWUPPowerUp AcquisitionN/A$0.38-8.6%N/A-96.4%$2.98MN/A0.00N/AHigh Trading VolumeMTNBMatinas Biopharma0.9999 of 5 stars$1.90-0.3%N/AN/A$9.64MN/A-0.3930News CoverageShort Interest ↓ADXNAddex Therapeutics0.4648 of 5 stars$9.18+2.7%$30.00+226.8%-2.1%$9.47M$460K-27.0030News CoverageEarnings ReportShort Interest ↑Gap UpAEONAEON Biopharma1.0019 of 5 stars$0.81-1.3%N/A-99.0%$9.42MN/A4.495ALBTAvalon GloboCare1.6707 of 5 stars$2.38-1.7%N/A-25.3%$9.28M$1.33M-0.125News CoveragePositive NewsShort Interest ↓Gap DownEPIXESSA Pharma3.8574 of 5 stars$0.19-1.2%$2.00+947.1%-96.6%$9.15MN/A-0.3450Dividend AnnouncementShort Interest ↓Gap UpQLGNQualigen TherapeuticsN/A$5.72+6.3%N/A-34.6%$9.12M$4.98M0.0050Gap UpKPRXKiora Pharmaceuticals3.4218 of 5 stars$2.78+5.7%$10.00+259.7%-21.2%$9.03M$16.02M-0.9610Positive NewsShort Interest ↓High Trading VolumeERNAErnexa Therapeutics0.6402 of 5 stars$1.10-6.4%N/A-91.6%$8.97M$580K-0.1310RNAZTransCode Therapeutics1.4996 of 5 stars$10.79+1.3%$280.00+2,495.0%-99.9%$8.88MN/A0.009News CoveragePositive NewsNLSPNLS PharmaceuticsN/A$1.83-25.3%N/A-59.0%$8.81MN/A0.006Short Interest ↑Gap DownHigh Trading Volume Related Companies and Tools Related Companies MTNB Competitors ADXN Competitors AEON Competitors ALBT Competitors EPIX Competitors QLGN Competitors KPRX Competitors ERNA Competitors RNAZ Competitors NLSP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PWUP) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PowerUp Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share PowerUp Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
